| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 1.37e-07 | 10 | 103 | 4 | GO:0005222 | |
| GeneOntologyMolecularFunction | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | 4.61e-07 | 13 | 103 | 4 | GO:0005221 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-activated monoatomic ion channel activity | 4.61e-07 | 13 | 103 | 4 | GO:0043855 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 7.01e-07 | 33 | 103 | 5 | GO:0005217 | |
| GeneOntologyMolecularFunction | disaccharide binding | 4.60e-06 | 7 | 103 | 3 | GO:0048030 | |
| GeneOntologyMolecularFunction | cAMP binding | 7.77e-06 | 25 | 103 | 4 | GO:0030552 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 9.15e-06 | 26 | 103 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | galactoside binding | 1.09e-05 | 9 | 103 | 3 | GO:0016936 | |
| GeneOntologyMolecularFunction | 5-diphosphoinositol pentakisphosphate 1-kinase activity | 2.64e-05 | 2 | 103 | 2 | GO:0033857 | |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 4.78e-05 | 39 | 103 | 4 | GO:0030551 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 1.43e-04 | 20 | 103 | 3 | GO:0070492 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.49e-04 | 52 | 103 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 3-kinase activity | 1.57e-04 | 4 | 103 | 2 | GO:0052724 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 1-kinase activity | 1.57e-04 | 4 | 103 | 2 | GO:0052723 | |
| GeneOntologyMolecularFunction | pancreatic polypeptide receptor activity | 1.57e-04 | 4 | 103 | 2 | GO:0001602 | |
| GeneOntologyMolecularFunction | diphosphoinositol pentakisphosphate kinase activity | 2.61e-04 | 5 | 103 | 2 | GO:0000829 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate kinase activity | 2.61e-04 | 5 | 103 | 2 | GO:0000828 | |
| GeneOntologyMolecularFunction | inositol-1,3,4,5,6-pentakisphosphate kinase activity | 2.61e-04 | 5 | 103 | 2 | GO:0000827 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 5-kinase activity | 2.61e-04 | 5 | 103 | 2 | GO:0000832 | |
| GeneOntologyMolecularFunction | channel activity | 3.83e-04 | 525 | 103 | 10 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 3.89e-04 | 526 | 103 | 10 | GO:0022803 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 4.03e-04 | 343 | 103 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 6.16e-04 | 459 | 103 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 7.11e-04 | 78 | 103 | 4 | GO:0043539 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 7.96e-04 | 140 | 103 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.15e-03 | 152 | 103 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | exonuclease activity | 1.32e-03 | 92 | 103 | 4 | GO:0004527 | |
| GeneOntologyMolecularFunction | U3 snoRNA binding | 1.41e-03 | 11 | 103 | 2 | GO:0034511 | |
| GeneOntologyMolecularFunction | inositol phosphate kinase activity | 1.41e-03 | 11 | 103 | 2 | GO:0180030 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 1.41e-03 | 11 | 103 | 2 | GO:0004983 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.43e-03 | 417 | 103 | 8 | GO:0061629 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity | 1.62e-03 | 45 | 103 | 3 | GO:0004532 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | HCN4 NOX5 HCN1 HCN3 SLC26A9 AQP7P3 HCN2 RYR1 SLC18A2 TRPV2 ATP5F1B | 1.83e-03 | 758 | 103 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 1.93e-03 | 102 | 103 | 4 | GO:0005249 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.93e-03 | 171 | 103 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | poly(A)-specific ribonuclease activity | 1.98e-03 | 13 | 103 | 2 | GO:0004535 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 2.19e-03 | 50 | 103 | 3 | GO:0003755 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.54e-03 | 182 | 103 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 2.59e-03 | 53 | 103 | 3 | GO:0016859 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.66e-03 | 184 | 103 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 3.16e-03 | 582 | 103 | 9 | GO:0140297 | |
| GeneOntologyMolecularFunction | isomerase activity | 3.19e-03 | 192 | 103 | 5 | GO:0016853 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.26e-03 | 193 | 103 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.56e-03 | 197 | 103 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | 3'-5' exonuclease activity | 3.86e-03 | 61 | 103 | 3 | GO:0008408 | |
| GeneOntologyMolecularFunction | potassium channel activity | 4.37e-03 | 128 | 103 | 4 | GO:0005267 | |
| GeneOntologyMolecularFunction | amide binding | 4.56e-03 | 299 | 103 | 6 | GO:0033218 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 5.12e-03 | 627 | 103 | 9 | GO:0022890 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 5.42e-03 | 310 | 103 | 6 | GO:0030246 | |
| GeneOntologyMolecularFunction | transcription factor binding | HIF1A PTPRT SIRT1 IFRD1 NFATC4 PRKCB CNOT1 HCFC1 EPAS1 DNMT3A | 5.51e-03 | 753 | 103 | 10 | GO:0008134 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 4.28e-07 | 4 | 99 | 3 | GO:0043322 | |
| GeneOntologyBiologicalProcess | cellular response to cGMP | 3.70e-06 | 7 | 99 | 3 | GO:0071321 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 5.90e-06 | 8 | 99 | 3 | GO:0043321 | |
| GeneOntologyBiologicalProcess | response to cGMP | 8.82e-06 | 9 | 99 | 3 | GO:0070305 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | NPR2 HCN4 HCN1 HCN3 HCN2 SIRT1 RYR1 GNA14 NFATC4 GNA15 CNOT1 DNMT3A | 3.29e-05 | 605 | 99 | 12 | GO:0071407 |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 4.68e-05 | 15 | 99 | 3 | GO:2000562 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 4.68e-05 | 15 | 99 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | response to organophosphorus | 6.34e-05 | 142 | 99 | 6 | GO:0046683 | |
| GeneOntologyBiologicalProcess | negative regulation of exocytosis | 6.40e-05 | 45 | 99 | 4 | GO:0045920 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 6.95e-05 | 17 | 99 | 3 | GO:0043301 | |
| GeneOntologyBiologicalProcess | positive regulation of oxidoreductase activity | 6.98e-05 | 46 | 99 | 4 | GO:0051353 | |
| GeneOntologyBiologicalProcess | natural killer cell degranulation | 8.31e-05 | 18 | 99 | 3 | GO:0043320 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell proliferation | 9.83e-05 | 19 | 99 | 3 | GO:0046642 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 9.83e-05 | 19 | 99 | 3 | GO:1900426 | |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 1.15e-04 | 20 | 99 | 3 | GO:0010819 | |
| GeneOntologyBiologicalProcess | cellular response to cAMP | 1.22e-04 | 53 | 99 | 4 | GO:0071320 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 1.34e-04 | 21 | 99 | 3 | GO:0032823 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | NPR2 HCN4 HCN1 HCN3 HCN2 ITGAM SIRT1 RYR1 GNA14 NFATC4 PRKCB GNA15 CNOT1 SDK1 DNMT3A | 1.38e-04 | 1048 | 99 | 15 | GO:0014070 |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 1.50e-04 | 166 | 99 | 6 | GO:0014074 | |
| GeneOntologyBiologicalProcess | leukocyte degranulation | 1.73e-04 | 108 | 99 | 5 | GO:0043299 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 2.11e-04 | 61 | 99 | 4 | GO:0003254 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte degranulation | 2.39e-04 | 63 | 99 | 4 | GO:0043300 | |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 2.57e-04 | 26 | 99 | 3 | GO:1900424 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2.70e-04 | 65 | 99 | 4 | GO:0000288 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell proliferation | 3.22e-04 | 28 | 99 | 3 | GO:2000561 | |
| GeneOntologyBiologicalProcess | microglia development | 3.38e-04 | 6 | 99 | 2 | GO:0014005 | |
| GeneOntologyBiologicalProcess | positive regulation of cytoplasmic mRNA processing body assembly | 3.38e-04 | 6 | 99 | 2 | GO:0010606 | |
| GeneOntologyBiologicalProcess | negative regulation of reactive oxygen species biosynthetic process | 3.58e-04 | 29 | 99 | 3 | GO:1903427 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell proliferation | 3.96e-04 | 30 | 99 | 3 | GO:0035739 | |
| GeneOntologyBiologicalProcess | action potential | 4.20e-04 | 201 | 99 | 6 | GO:0001508 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte chemotaxis | 4.37e-04 | 31 | 99 | 3 | GO:1901623 | |
| GeneOntologyBiologicalProcess | positive regulation of regulatory T cell differentiation | 4.37e-04 | 31 | 99 | 3 | GO:0045591 | |
| GeneOntologyBiologicalProcess | myoblast fate commitment | 4.71e-04 | 7 | 99 | 2 | GO:0048625 | |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 4.81e-04 | 32 | 99 | 3 | GO:1903306 | |
| GeneOntologyBiologicalProcess | T cell chemotaxis | 5.27e-04 | 33 | 99 | 3 | GO:0010818 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion by cell | 5.84e-04 | 214 | 99 | 6 | GO:1903531 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic mRNA processing body assembly | 6.27e-04 | 8 | 99 | 2 | GO:0010603 | |
| GeneOntologyBiologicalProcess | regulation of Rac protein signal transduction | 6.28e-04 | 35 | 99 | 3 | GO:0035020 | |
| GeneOntologyCellularComponent | HCN channel complex | 5.34e-10 | 4 | 102 | 4 | GO:0098855 | |
| GeneOntologyCellularComponent | distal axon | RASGRF1 HCN4 HCN1 HCN3 ALS2 SIRT1 IGF2BP1 NEO1 SLC18A2 TRPV2 PRKCB | 9.09e-06 | 435 | 102 | 11 | GO:0150034 |
| GeneOntologyCellularComponent | axon | HIF1A RASGRF1 HCN4 HCN1 KIF1B HCN3 ALS2 HCN2 SIRT1 IGF2BP1 NEO1 SLC18A2 TRPV2 PRKCB HCFC1 | 2.70e-05 | 891 | 102 | 15 | GO:0030424 |
| MousePheno | enhanced humoral immune response | 2.85e-06 | 17 | 85 | 4 | MP:0020155 | |
| MousePheno | increased T-helper 1 cell number | 4.60e-06 | 19 | 85 | 4 | MP:0008086 | |
| MousePheno | abnormal T-helper 1 cell number | 1.23e-05 | 24 | 85 | 4 | MP:0008085 | |
| MousePheno | pulmonary artery hypoplasia | 3.46e-05 | 11 | 85 | 3 | MP:0010460 | |
| Domain | Ion_trans_N | 8.38e-10 | 4 | 102 | 4 | IPR013621 | |
| Domain | Ion_trans_N | 8.38e-10 | 4 | 102 | 4 | PF08412 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 8.05e-07 | 14 | 102 | 4 | IPR003938 | |
| Domain | Galectin_CRD | 1.09e-06 | 15 | 102 | 4 | IPR001079 | |
| Domain | Gal-bind_lectin | 1.09e-06 | 15 | 102 | 4 | PF00337 | |
| Domain | Gal-bind_lectin | 1.09e-06 | 15 | 102 | 4 | SM00908 | |
| Domain | GALECTIN | 1.09e-06 | 15 | 102 | 4 | PS51304 | |
| Domain | GLECT | 1.09e-06 | 15 | 102 | 4 | SM00276 | |
| Domain | - | 1.34e-05 | 95 | 102 | 6 | 2.60.120.200 | |
| Domain | ConA-like_dom | 2.68e-05 | 219 | 102 | 8 | IPR013320 | |
| Domain | CNMP_BINDING_1 | 2.68e-05 | 32 | 102 | 4 | PS00888 | |
| Domain | CNMP_BINDING_2 | 2.68e-05 | 32 | 102 | 4 | PS00889 | |
| Domain | AARP2CN | 2.95e-05 | 2 | 102 | 2 | SM00785 | |
| Domain | HIF-1a_CTAD | 2.95e-05 | 2 | 102 | 2 | PF08778 | |
| Domain | G_Bms1/Tsr1_dom | 2.95e-05 | 2 | 102 | 2 | IPR030387 | |
| Domain | AARP2CN | 2.95e-05 | 2 | 102 | 2 | IPR012948 | |
| Domain | AARP2CN | 2.95e-05 | 2 | 102 | 2 | PF08142 | |
| Domain | HIF-1_TAD_C | 2.95e-05 | 2 | 102 | 2 | IPR014887 | |
| Domain | BMS1_TSR1_C | 2.95e-05 | 2 | 102 | 2 | IPR007034 | |
| Domain | RIBIOP_C | 2.95e-05 | 2 | 102 | 2 | PF04950 | |
| Domain | NPY4_rcpt | 2.95e-05 | 2 | 102 | 2 | IPR001933 | |
| Domain | DUF663 | 2.95e-05 | 2 | 102 | 2 | SM01362 | |
| Domain | G_BMS1 | 2.95e-05 | 2 | 102 | 2 | PS51714 | |
| Domain | cNMP | 3.43e-05 | 34 | 102 | 4 | SM00100 | |
| Domain | cNMP_binding | 3.43e-05 | 34 | 102 | 4 | PF00027 | |
| Domain | Ion_trans_dom | 3.79e-05 | 114 | 102 | 6 | IPR005821 | |
| Domain | Ion_trans | 3.79e-05 | 114 | 102 | 6 | PF00520 | |
| Domain | cNMP-bd_dom | 3.85e-05 | 35 | 102 | 4 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 3.85e-05 | 35 | 102 | 4 | PS50042 | |
| Domain | cNMP-bd-like | 5.37e-05 | 38 | 102 | 4 | IPR018490 | |
| Domain | cNMP-bd_CS | 8.41e-05 | 16 | 102 | 3 | IPR018488 | |
| Domain | HIF_alpha_subunit | 8.83e-05 | 3 | 102 | 2 | IPR021537 | |
| Domain | HIF-1 | 8.83e-05 | 3 | 102 | 2 | PF11413 | |
| Domain | FN3 | 1.10e-04 | 199 | 102 | 7 | PS50853 | |
| Domain | - | 1.36e-04 | 48 | 102 | 4 | 2.60.120.10 | |
| Domain | FN3_dom | 1.49e-04 | 209 | 102 | 7 | IPR003961 | |
| Domain | RmlC-like_jellyroll | 1.72e-04 | 51 | 102 | 4 | IPR014710 | |
| Domain | Gprotein_alpha_Q | 1.76e-04 | 4 | 102 | 2 | IPR000654 | |
| Domain | Acid_Pase_AS | 4.37e-04 | 6 | 102 | 2 | IPR033379 | |
| Domain | FN3 | 5.34e-04 | 185 | 102 | 6 | SM00060 | |
| Domain | HIS_ACID_PHOSPHAT_2 | 6.09e-04 | 7 | 102 | 2 | PS00778 | |
| Domain | HIS_ACID_PHOSPHAT_1 | 6.09e-04 | 7 | 102 | 2 | PS00616 | |
| Domain | His_Pase_clade-2 | 8.09e-04 | 8 | 102 | 2 | IPR000560 | |
| Domain | His_Phos_2 | 8.09e-04 | 8 | 102 | 2 | PF00328 | |
| Domain | NPY_rcpt | 1.04e-03 | 9 | 102 | 2 | IPR000611 | |
| Domain | fn3 | 1.95e-03 | 162 | 102 | 5 | PF00041 | |
| Domain | GproteinA_insert | 3.37e-03 | 16 | 102 | 2 | IPR011025 | |
| Domain | - | 3.37e-03 | 16 | 102 | 2 | 1.10.400.10 | |
| Domain | G-alpha | 3.37e-03 | 16 | 102 | 2 | PF00503 | |
| Domain | G_alpha | 3.37e-03 | 16 | 102 | 2 | SM00275 | |
| Domain | Gprotein_alpha_su | 3.81e-03 | 17 | 102 | 2 | IPR001019 | |
| Domain | Cyclophilin-type_PPIase_CS | 4.75e-03 | 19 | 102 | 2 | IPR020892 | |
| Domain | - | 5.26e-03 | 20 | 102 | 2 | 3.40.50.1240 | |
| Domain | His_PPase_superfam | 5.26e-03 | 20 | 102 | 2 | IPR029033 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 16043489 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 9405696 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 12928435 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 20140458 | ||
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 22748890 | ||
| Pubmed | Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. | 7.25e-11 | 4 | 103 | 4 | 9630217 | |
| Pubmed | 7.25e-11 | 4 | 103 | 4 | 21615589 | ||
| Pubmed | Regulation of HCN channel surface expression by a novel C-terminal protein-protein interaction. | 3.62e-10 | 5 | 103 | 4 | 15564593 | |
| Pubmed | 3.62e-10 | 5 | 103 | 4 | 34429357 | ||
| Pubmed | The glucose transporter 2 regulates CD8+ T cell function via environment sensing. | 3.62e-10 | 5 | 103 | 4 | 37884694 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MPDU1 WRN BMS1 LGALS9 RABL6 FARSA IGF2BP1 FASN TSR1 DNAJC11 HPF1 PRKCB NKTR PPIP5K2 PCCB RPL3 HCFC1 PHIP RPL9 ATP5F1B | 1.67e-09 | 1318 | 103 | 20 | 30463901 |
| Pubmed | 2.52e-09 | 7 | 103 | 4 | 27956497 | ||
| Pubmed | Transcription profiling of HCN-channel isotypes throughout mouse cardiac development. | 2.52e-09 | 7 | 103 | 4 | 19421833 | |
| Pubmed | 4.05e-09 | 21 | 103 | 5 | 30270038 | ||
| Pubmed | 5.03e-09 | 8 | 103 | 4 | 31661141 | ||
| Pubmed | 1.50e-08 | 10 | 103 | 4 | 16382102 | ||
| Pubmed | LGALS9C LGALS9B MPDU1 LGALS9 FARSA IGF2BP1 FASN PCCB RPL3 CNOT1 RPL9 ATP5F1B | 2.24e-08 | 484 | 103 | 12 | 31995728 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 19776007 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 33316546 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 9038233 | ||
| Pubmed | Ventricular HCN channels decrease the repolarization reserve in the hypertrophic heart. | 2.52e-08 | 3 | 103 | 3 | 22652004 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 28704475 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 23836896 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 21187420 | ||
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 2.52e-08 | 3 | 103 | 3 | 7890611 | |
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 2.52e-08 | 3 | 103 | 3 | 22341088 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 32380082 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 23667648 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 21945247 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 28877989 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 19800850 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 22006928 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 38987795 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 37105392 | ||
| Pubmed | Differential roles of Sirt1 in HIF-1α and HIF-2α mediated hypoxic responses. | 2.52e-08 | 3 | 103 | 3 | 24423936 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 36479526 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 23242525 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 2.52e-08 | 3 | 103 | 3 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 2.52e-08 | 3 | 103 | 3 | 33923930 | |
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 2.52e-08 | 3 | 103 | 3 | 31969388 | |
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 2.52e-08 | 3 | 103 | 3 | 35241678 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 22627368 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 33153471 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 22052881 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 35643073 | ||
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 2.52e-08 | 3 | 103 | 3 | 23408620 | |
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 2.52e-08 | 3 | 103 | 3 | 29458010 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 26582205 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 9153289 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 33181864 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 18974023 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 23144904 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 2.52e-08 | 3 | 103 | 3 | 29651447 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 21146220 | ||
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 2.52e-08 | 3 | 103 | 3 | 28990062 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 18579572 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 16990264 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 18005988 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 23585851 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 24477688 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 2.52e-08 | 3 | 103 | 3 | 29433546 | |
| Pubmed | Alarmin function of galectin-9 in murine respiratory tularemia. | 2.52e-08 | 3 | 103 | 3 | 25898318 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 31937306 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 21426359 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 18282810 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 24083426 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 37279535 | ||
| Pubmed | The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. | 2.52e-08 | 3 | 103 | 3 | 25931247 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 17560833 | ||
| Pubmed | A family of hyperpolarization-activated mammalian cation channels. | 2.52e-08 | 3 | 103 | 3 | 9634236 | |
| Pubmed | Pacsin 2 is required for the maintenance of a normal cardiac function in the developing mouse heart. | 7.10e-08 | 14 | 103 | 4 | 29107716 | |
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 38686388 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 22677125 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 19234217 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 35715604 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 19017954 | ||
| Pubmed | Galectin-9: A novel promoter of atherosclerosis progression. | 1.01e-07 | 4 | 103 | 3 | 36459823 | |
| Pubmed | Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. | 1.01e-07 | 4 | 103 | 3 | 29611821 | |
| Pubmed | Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2. | 1.01e-07 | 4 | 103 | 3 | 33727589 | |
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 25578313 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 18826117 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 38853593 | ||
| Pubmed | [Expression of Galectin-9 and Tim-3 in lungs of mice with asthma]. | 1.01e-07 | 4 | 103 | 3 | 21575348 | |
| Pubmed | Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. | 1.01e-07 | 4 | 103 | 3 | 18346632 | |
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 19670381 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 25450716 | ||
| Pubmed | The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. | 1.01e-07 | 4 | 103 | 3 | 16286920 | |
| Pubmed | Galectin-9 regulates the threshold of B cell activation and autoimmunity. | 1.01e-07 | 4 | 103 | 3 | 34369876 | |
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 33203936 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 25042871 | ||
| Pubmed | Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons. | 1.01e-07 | 4 | 103 | 3 | 26966193 | |
| Pubmed | Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation. | 1.01e-07 | 4 | 103 | 3 | 33963043 | |
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 33107565 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 30763585 | ||
| Pubmed | Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. | 1.01e-07 | 4 | 103 | 3 | 19362679 | |
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 29844236 | ||
| Pubmed | Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. | 1.01e-07 | 4 | 103 | 3 | 20463811 | |
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 32855403 | ||
| Pubmed | Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain. | 1.01e-07 | 4 | 103 | 3 | 23657851 | |
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 24333756 | ||
| Interaction | HCN4 interactions | 7.64e-08 | 9 | 102 | 4 | int:HCN4 | |
| Interaction | LGALS9 interactions | LGALS9C LGALS9B MPDU1 LGALS9 FARSA IGF2BP1 FASN PCCB RPL3 CNOT1 RPL9 ATP5F1B DNMT3A | 8.44e-06 | 588 | 102 | 13 | int:LGALS9 |
| Interaction | HCN3 interactions | 2.02e-05 | 11 | 102 | 3 | int:HCN3 | |
| Interaction | NR2C2 interactions | MPDU1 WRN BMS1 LGALS9 RABL6 FARSA IGF2BP1 FASN TSR1 DNAJC11 HPF1 PRKCB NKTR PPIP5K2 PCCB RPL3 HCFC1 PHIP RPL9 ATP5F1B | 2.11e-05 | 1403 | 102 | 20 | int:NR2C2 |
| Interaction | HCN2 interactions | 3.47e-05 | 13 | 102 | 3 | int:HCN2 | |
| GeneFamily | Cyclic nucleotide gated channels | 6.60e-08 | 10 | 78 | 4 | 250 | |
| GeneFamily | Galectins | 4.22e-07 | 15 | 78 | 4 | 629 | |
| GeneFamily | Fibronectin type III domain containing | 6.40e-04 | 160 | 78 | 5 | 555 | |
| GeneFamily | CCR4-NOT transcription complex | 9.85e-04 | 11 | 78 | 2 | 1023 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 3.00e-03 | 19 | 78 | 2 | 909 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-08 | 196 | 103 | 8 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-08 | 196 | 103 | 8 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | T_cells-Tph_and_Tfh|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.80e-07 | 176 | 103 | 7 | 56c055488e34605d32562571a2fee621b47c9441 | |
| ToppCell | CF|World / Disease state, Lineage and Cell class | 2.71e-07 | 187 | 103 | 7 | eec4d4e4a658e3a61c05745167a1a5e3d39bb43e | |
| ToppCell | HSPCs-Ery_prog.|HSPCs / Lineage and Cell class | 2.91e-07 | 189 | 103 | 7 | 37d2c45debed1564a40a1085b8b310c50923b9e7 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.99e-07 | 198 | 103 | 7 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-06 | 144 | 103 | 6 | 013223bb2f31eb5bebdbd0908b797d28b96c6f7b | |
| ToppCell | Adult-Immune-mast_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.65e-06 | 155 | 103 | 6 | 7c9de0591d1bf756b8e268b278bbe10bd5415dcd | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-06 | 175 | 103 | 6 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.87e-06 | 187 | 103 | 6 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.83e-06 | 193 | 103 | 6 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 6.19e-06 | 195 | 103 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.75e-06 | 198 | 103 | 6 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.95e-06 | 199 | 103 | 6 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD3|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.95e-06 | 199 | 103 | 6 | 4be4527f351b701438a8bcb738229a06dbf8bc96 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD3-NKT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.95e-06 | 199 | 103 | 6 | d3dc52e1f0040763888f951a7c047db4a329a653 | |
| ToppCell | Healthy/Control|World / Disease group and Cell class | 6.95e-06 | 199 | 103 | 6 | 2623c42b3e79e401a485879b52e8bbcbc581544d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 7.15e-06 | 200 | 103 | 6 | 7c495030e6566b81d97b5516d1972e335ce5ed8c | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.51e-05 | 149 | 103 | 5 | f4bee5fdaaa4a1917e403de90e5a62353006df24 | |
| ToppCell | Control-Myeloid-Monocytes,_Macrophages-Mast-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.43e-05 | 159 | 103 | 5 | 81782e9e370558d61af5e0c760ac9759d69fb725 | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 3.53e-05 | 160 | 103 | 5 | 5744cd30709f38e84f7ec8893dc19d7a288b465a | |
| ToppCell | Adult-Immune-mast_cell|Adult / Lineage, Cell type, age group and donor | 3.64e-05 | 161 | 103 | 5 | 44f5c0256b3ce264a6c7b62740f32dcd45ee052d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 3.86e-05 | 163 | 103 | 5 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.46e-05 | 168 | 103 | 5 | c7021748003e5949f7caf7b3291c5bad294948c1 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.46e-05 | 168 | 103 | 5 | e20e1936573fdde78426d7a4eb45c458d5c4dbb4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.46e-05 | 168 | 103 | 5 | 16b517e3159ad6e6d25fd48f7d5f46e77b2b318d | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 4.58e-05 | 169 | 103 | 5 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.58e-05 | 169 | 103 | 5 | f68195510b91e287fe1507455ca067ece77a3897 | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 4.71e-05 | 170 | 103 | 5 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | CF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 5.41e-05 | 175 | 103 | 5 | 8020c3a34f77e68e8149f87481fb1dddd2ac675e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.56e-05 | 176 | 103 | 5 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.18e-05 | 180 | 103 | 5 | 30cf3c7ee29694eaccb89bf8053a82037d5c9f1d | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.86e-05 | 184 | 103 | 5 | 0ba243cbf69b4fe6ae100a7f0314317bec38026c | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.86e-05 | 184 | 103 | 5 | a809b0fa52df8a159f60f87eefcef61220af5e34 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.86e-05 | 184 | 103 | 5 | 2a8338e94937686a148b5433515700ca0f674058 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-05 | 185 | 103 | 5 | fd1911b57927c03470f9387962ca9581e5643fb3 | |
| ToppCell | facs-Large_Intestine-Distal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-05 | 185 | 103 | 5 | 7a18d525de6f874924bfc61b9666b307da86421a | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.59e-05 | 188 | 103 | 5 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.59e-05 | 188 | 103 | 5 | ab95a97db1a84bf3e53a4616a83ee81a6ce5ec12 | |
| ToppCell | HSPCs-Ery/Mk_prog.|World / Lineage and Cell class | 7.59e-05 | 188 | 103 | 5 | 5390089213cd6ee90dcdfd3c3f5b6765376cccf2 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 7.59e-05 | 188 | 103 | 5 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.78e-05 | 189 | 103 | 5 | bed43041e6f8ba19787150a6aaa492f2656135d9 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.78e-05 | 189 | 103 | 5 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 7.78e-05 | 189 | 103 | 5 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.18e-05 | 191 | 103 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | COVID-19-lung-CD8+_T_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.18e-05 | 191 | 103 | 5 | 543f8ae07cc2e6950c888115a5ca9445e3c0f618 | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 8.18e-05 | 191 | 103 | 5 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.38e-05 | 192 | 103 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.38e-05 | 192 | 103 | 5 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 8.38e-05 | 192 | 103 | 5 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.38e-05 | 192 | 103 | 5 | aee6522d25e012231cdb905ce047295cb64d6e82 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-05 | 192 | 103 | 5 | 88472b99970ba0decbf87164fc241a1c77b3b389 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.38e-05 | 192 | 103 | 5 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 8.38e-05 | 192 | 103 | 5 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | COVID-19-kidney-Myeloid|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.38e-05 | 192 | 103 | 5 | 0b9d22a222f1201e375f8e55cace9ef939febae4 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.59e-05 | 193 | 103 | 5 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass | 8.59e-05 | 193 | 103 | 5 | 7fcd6139ac3e1384a1017b6b8152e3431e056f6a | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 193 | 103 | 5 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 8.59e-05 | 193 | 103 | 5 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 193 | 103 | 5 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | COVID-19-lung-CD8+_T_cells|lung / Disease (COVID-19 only), tissue and cell type | 8.59e-05 | 193 | 103 | 5 | 780e23e2705fc5c1b70e37568b79731ced5038bd | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.59e-05 | 193 | 103 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.59e-05 | 193 | 103 | 5 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 8.59e-05 | 193 | 103 | 5 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 8.80e-05 | 194 | 103 | 5 | 4547b57669be5d4f0de55175802ee04372288a6a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.80e-05 | 194 | 103 | 5 | 1dce6d4b6ac41f80677e3e4c335a4f383bd76f85 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.80e-05 | 194 | 103 | 5 | 54975e663ed4414b99b3c9a1aa6335613946470f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-05 | 194 | 103 | 5 | b8a130ffae68ffe550bf335460a1ec1035cf8d8d | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 8.80e-05 | 194 | 103 | 5 | 2a144a1c2d537c8a59aa419206ddd96c23f0aeab | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 9.01e-05 | 195 | 103 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | AT2_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 9.01e-05 | 195 | 103 | 5 | 33f60762f00cd6f4757d8a8d5227141558ac823e | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 9.01e-05 | 195 | 103 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 9.01e-05 | 195 | 103 | 5 | bff726515ea9ce82c223e6c805000afe2e9b7206 | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.01e-05 | 195 | 103 | 5 | 7e0ef92059ff34e368d2324815f49b50e3ca7332 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.23e-05 | 196 | 103 | 5 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 9.23e-05 | 196 | 103 | 5 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-Gamma_Delta_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 9.23e-05 | 196 | 103 | 5 | 6eabbac1625f715531bae562a28da27664572600 | |
| ToppCell | (05)_Secretory|World / shred by cell type by condition | 9.23e-05 | 196 | 103 | 5 | 8032c25b51ef96aeba28cc52686a2bd45213453d | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 9.23e-05 | 196 | 103 | 5 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|Epithelial / Condition, Lineage and Cell class | 9.46e-05 | 197 | 103 | 5 | 78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.46e-05 | 197 | 103 | 5 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.46e-05 | 197 | 103 | 5 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 198 | 103 | 5 | af07a970afaa435c6433bb5c1cbff4c67af350c7 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.69e-05 | 198 | 103 | 5 | 3bc05b8d97a7219af40db7a11aa271f02e74fca5 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 198 | 103 | 5 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 198 | 103 | 5 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | Sigmoid-(1)_T_cell-(14)_Tcm|Sigmoid / shred on region, Cell_type, and subtype | 9.92e-05 | 199 | 103 | 5 | ec454fa22fb7f50a947bdf4c4bb6f0ba13f62b4c | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.92e-05 | 199 | 103 | 5 | 5919933c4b842b98fc98685dc8c72c8dd32c6ea3 | |
| ToppCell | Sigmoid-T_cell-Tcm|T_cell / Region, Cell class and subclass | 9.92e-05 | 199 | 103 | 5 | acdf95f4d58df47690f4ae254245bc618f9ac07e | |
| ToppCell | Mild/Remission-B_intermediate-0|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.92e-05 | 199 | 103 | 5 | 592111591f0f6816fc56620cb555eb48dabf0758 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.92e-05 | 199 | 103 | 5 | b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.92e-05 | 199 | 103 | 5 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | distal-1-Endothelial-Artery|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.92e-05 | 199 | 103 | 5 | fd71d08f6de790a29c880d50d2ed0881952d7791 | |
| ToppCell | Sigmoid-T_cell-Tcm|Sigmoid / Region, Cell class and subclass | 9.92e-05 | 199 | 103 | 5 | f7c729eaa3c8fd5a05cb6f79cac9b8f199c8092b | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.92e-05 | 199 | 103 | 5 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.92e-05 | 199 | 103 | 5 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 9.92e-05 | 199 | 103 | 5 | 8e72efcd421639ac36ed036ee13f13de070d361f | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.92e-05 | 199 | 103 | 5 | caf2e050b21e7a16ce4e51b3f135debd06810231 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 103 | 5 | a3fcd901cb281920f1bafdfd676399a6dc37355e | |
| ToppCell | healthy_donor|World / Disease condition, Lineage, Cell class and subclass | 1.02e-04 | 200 | 103 | 5 | afd4d5609adaa470e3d880f8be4a4d55e162b3d6 | |
| Drug | cyanide | 2.17e-07 | 254 | 102 | 10 | CID000000768 | |
| Drug | HCNs | 1.74e-06 | 20 | 102 | 4 | CID006857665 | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.76e-06 | 195 | 102 | 8 | 6927_DN | |
| Drug | R59949 | 1.57e-05 | 70 | 102 | 5 | CID000657356 | |
| Drug | nonivamide | 1.86e-05 | 12 | 102 | 3 | CID000002998 | |
| Drug | cycloheterophyllin | 1.99e-05 | 2 | 102 | 2 | CID005316250 | |
| Drug | Nitric Oxide | 2.05e-05 | 336 | 102 | 9 | ctd:D009569 | |
| Drug | ivabradine | 2.77e-05 | 39 | 102 | 4 | CID000132999 | |
| Drug | Riboflavine [83-88-5]; Down 200; 10.6uM; HL60; HG-U133A | 2.91e-05 | 196 | 102 | 7 | 1767_DN | |
| Disease | amino acid metabolic disorder (is_implicated_in) | 5.57e-06 | 11 | 97 | 3 | DOID:9252 (is_implicated_in) | |
| Disease | meningitis (biomarker_via_orthology) | 1.07e-05 | 2 | 97 | 2 | DOID:9471 (biomarker_via_orthology) | |
| Disease | sick sinus syndrome (implicated_via_orthology) | 3.20e-05 | 3 | 97 | 2 | DOID:13884 (implicated_via_orthology) | |
| Disease | cutaneous melanoma, hair color | 5.29e-05 | 62 | 97 | 4 | EFO_0000389, EFO_0003924 | |
| Disease | waist circumference | 8.74e-05 | 429 | 97 | 8 | EFO_0004342 | |
| Disease | galectin-9 measurement | 1.06e-04 | 5 | 97 | 2 | EFO_0021863 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.43e-04 | 80 | 97 | 4 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 3.79e-04 | 9 | 97 | 2 | C3502809 | |
| Disease | triglycerides in large LDL measurement | 3.86e-04 | 43 | 97 | 3 | EFO_0022319 | |
| Disease | middle cerebral artery infarction (implicated_via_orthology) | 4.42e-04 | 45 | 97 | 3 | DOID:3525 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 5.15e-04 | 702 | 97 | 9 | C0009402 | |
| Disease | bronchopulmonary dysplasia (biomarker_via_orthology) | 6.91e-04 | 12 | 97 | 2 | DOID:11650 (biomarker_via_orthology) | |
| Disease | collagen disease (implicated_via_orthology) | 6.91e-04 | 12 | 97 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | anxiety disorder, stress-related disorder | 6.91e-04 | 12 | 97 | 2 | EFO_0006788, EFO_0010098 | |
| Disease | triglycerides in LDL measurement | 8.41e-04 | 56 | 97 | 3 | EFO_0022320 | |
| Disease | pre-eclampsia (is_marker_for) | 9.32e-04 | 58 | 97 | 3 | DOID:10591 (is_marker_for) | |
| Disease | primary biliary cirrhosis | 9.89e-04 | 133 | 97 | 4 | EFO_1001486 | |
| Disease | HSV2 virologic severity measurement | 1.09e-03 | 15 | 97 | 2 | EFO_0009010 | |
| Disease | P wave duration | 1.09e-03 | 15 | 97 | 2 | EFO_0005094 | |
| Disease | Profound Mental Retardation | 1.16e-03 | 139 | 97 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.16e-03 | 139 | 97 | 4 | C0025363 | |
| Disease | Mental deficiency | 1.16e-03 | 139 | 97 | 4 | C0917816 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.43e-03 | 147 | 97 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | free androgen index | 1.49e-03 | 374 | 97 | 6 | EFO_0007005 | |
| Disease | Disorder of organic acid metabolism | 1.58e-03 | 18 | 97 | 2 | cv:C1263739 | |
| Disease | cerebral infarction (is_marker_for) | 1.76e-03 | 19 | 97 | 2 | DOID:3526 (is_marker_for) | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 1.76e-03 | 19 | 97 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | Paroxysmal atrial fibrillation | 1.78e-03 | 156 | 97 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 1.78e-03 | 156 | 97 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.78e-03 | 156 | 97 | 4 | C2585653 | |
| Disease | Atrial Fibrillation | 1.95e-03 | 160 | 97 | 4 | C0004238 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 1.96e-03 | 20 | 97 | 2 | DOID:3328 (is_marker_for) | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.37e-03 | 22 | 97 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | leptin measurement | 2.44e-03 | 81 | 97 | 3 | EFO_0005000 | |
| Disease | triacylglycerol 54:8 measurement | 2.59e-03 | 23 | 97 | 2 | EFO_0010426 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 2.59e-03 | 23 | 97 | 2 | C1708353 | |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 2.94e-03 | 295 | 97 | 5 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 | |
| Disease | total brain volume change measurement, age at assessment | 3.05e-03 | 25 | 97 | 2 | EFO_0008007, EFO_0021504 | |
| Disease | testosterone measurement | 3.12e-03 | 1275 | 97 | 11 | EFO_0004908 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QVVSGQYRMLAKHGG | 301 | Q99814 | |
| GQSMRVGYTLVKHSQ | 1461 | Q14031 | |
| VGGMKEIALHTNRQY | 966 | Q63HQ2 | |
| RHQGKIMYVGDVRSV | 676 | Q9Y6K1 | |
| VKYLRQHIGNTLGSM | 56 | Q96NH3 | |
| YLQHGEQGIMFTTLK | 1631 | Q96Q42 | |
| KQMFGPQVLTTRHYV | 151 | Q13227 | |
| ILKGIYHQSMSQIYG | 6031 | Q8WXG9 | |
| TGMVTFYIKGTLQHA | 311 | P32929 | |
| KILMVQSFSHQYAGI | 111 | Q6MZZ7 | |
| RRYHGVTGLVVMDKN | 371 | P20594 | |
| EGNVGYVQMRLKKHR | 916 | Q14692 | |
| HQGQEAILQRYRMKG | 246 | Q96C86 | |
| SFFLQMQKRVSGHYV | 866 | Q53SF7 | |
| IMELINNVAKAHGGY | 216 | P06576 | |
| LVHMQGGILFVYDNK | 221 | Q01432 | |
| QMFHQYSFRGKDLIV | 121 | Q9HCJ3 | |
| FHYLIMAKGVIVRSG | 491 | P20742 | |
| FAKGVQYNMKIVIRG | 36 | Q3YEC7 | |
| QYIPMHGKQIRGLAF | 491 | Q6PCD5 | |
| QTIIIGDNKTQYHMG | 116 | Q9NWY4 | |
| IQFHQLMGYVVVGLS | 311 | Q96PH1 | |
| VYMLNVKGLARGVFQ | 146 | Q7Z4N8 | |
| QYNFAMNVLGRVKGR | 1236 | Q8TEM1 | |
| GVIKGTNVMVTHYFL | 1816 | P51610 | |
| KVLYQFRGVLHQVMV | 526 | Q9NVH1 | |
| HQFQRMGKLISLFYT | 256 | Q8NH19 | |
| GTYSLRAGHMKQVNV | 251 | P50391 | |
| VNKYMGLTQFELTGH | 116 | Q16665 | |
| IVKIIGHFYASQMAQ | 536 | Q9NZI8 | |
| GNRIIMGKNHVFRFN | 621 | O60333 | |
| KVMVNGSLFVQYFHR | 111 | Q6DKI2 | |
| VIIRVYHGMNTGYAI | 211 | A6NL99 | |
| KVMVNGSLFVQYFHR | 111 | Q3B8N2 | |
| KVMVNGILFVQYFHR | 111 | O00182 | |
| KYHLTVAQVRGGMVF | 571 | Q04609 | |
| IMVGIFSTHYFQQKV | 636 | Q99665 | |
| FLGILNKYMEIHGTV | 481 | Q3V5L5 | |
| VKTKFGYHIIMVEGR | 116 | Q9Y237 | |
| RQIAQEIIKGMGYLH | 711 | Q8IVT5 | |
| GDLMYHIQQVGRFKE | 426 | P05771 | |
| MIFKRLHLGTVAYGL | 401 | O75110 | |
| STFIKQMRIIHGAGY | 56 | P30679 | |
| VREGSVGRKMYFIQH | 456 | Q9P1Z3 | |
| VGRKMYFIQHGLLSV | 461 | Q9P1Z3 | |
| ANILGHENKGVYVLM | 266 | P26440 | |
| VREAFGQKIGHFQLM | 311 | P26440 | |
| YKVTLGQMHGLLTER | 451 | Q9P0J1 | |
| GTIGKKMYFIQHGVV | 626 | Q9Y3Q4 | |
| QHITQMKRGQGYGFK | 876 | O14522 | |
| YAKNIIVGFARMNGR | 336 | P05166 | |
| KMYFIQHGVAGVITK | 511 | O60741 | |
| IQFMKQVHQGVRGFV | 786 | O75976 | |
| TFKEVLGSGMQYHLQ | 376 | O00458 | |
| VNRTYQMHLGGKQRE | 171 | Q8N6P7 | |
| VLEGTGKSQMYVQHR | 251 | Q12794 | |
| LKFHIYNVGTRGLDM | 276 | Q8WTQ7 | |
| RYMAQGKHIGKVVVQ | 1841 | P49327 | |
| YTHYRFRMKQVNIVG | 1141 | Q7Z5N4 | |
| RMIHSTNGLYNQFIK | 401 | P21817 | |
| TIGKKMYFIQHGVVS | 576 | Q9UL51 | |
| MYFIQHGVVSVLTKG | 581 | Q9UL51 | |
| RYVSMGQGQEVHARK | 4071 | Q8TE73 | |
| NMYGFRKVVHIDSGI | 66 | Q03933 | |
| FIKQMRIIHGSGYSD | 51 | O95837 | |
| MIKYGINNIRELVGH | 466 | Q9Y285 | |
| ILKYKTQFEGMNHRV | 1301 | Q8WXH0 | |
| KYHMQIVGEIQRGFP | 306 | Q7LBE3 | |
| ELYHQKSVLIMGRGY | 551 | Q06210 | |
| FYQVHRITGKMVATA | 481 | Q14934 | |
| GSTFHRVVKNFMIQG | 61 | P30414 | |
| FLGYKAGMTHIVREV | 46 | P39023 | |
| FMNYARKVGAVGRVN | 371 | O14975 | |
| ATVYIFRVMAQNKHG | 506 | Q92859 | |
| RIGPYTFVQQHLMIG | 181 | Q96EB6 | |
| MGINKADIRQVIHYG | 826 | Q14191 | |
| FIFGQHLRQQRMGTY | 246 | P13598 | |
| YQHIGLVAMFRQNTG | 426 | P11215 | |
| KGRIGVVISSYMHFT | 111 | Q68CZ2 | |
| IMFLHQIFYQGLKAR | 296 | Q13972 | |
| ICFLVMHYRGQTVKG | 116 | O75352 | |
| MHYRGQTVKGVAFLA | 121 | O75352 | |
| RIQVLSMYGKQAGFI | 236 | Q9BXI2 | |
| IFYSKTHMNVLGVLG | 491 | Q96LI5 | |
| FSAFVGQMHQQGILK | 1876 | A5YKK6 | |
| MQKRHRVFFVYVGGE | 146 | Q96JJ7 | |
| NRLLHIVGYGDFQMK | 286 | Q2NL82 | |
| KIRSYFNMIEGQGHG | 501 | Q8WWQ0 | |
| HVQNMIKGVTLGFRY | 76 | P32969 | |
| IFHRNIKGFMVQTGD | 41 | Q9H2H8 | |
| RIFQAITGLIQHYMK | 2181 | O60281 | |
| GFQHTGIYSVMIQKV | 516 | Q9Y5S1 | |
| GTYSLRAGHMKQVNV | 251 | P0DQD5 | |
| MIVTGQYGRLFAVVH | 86 | Q7Z2W9 | |
| IFQEAHGMVARKQFG | 696 | P11277 | |
| HRVGFQYQGIMQKHT | 396 | P49750 | |
| KVMVNGQRIYNFAHR | 101 | Q8TCE9 | |
| CGKGFTMKRYLIVHQ | 546 | O94892 | |
| QFRYQVMSGPHETLK | 46 | P17022 | |
| IGKGVAIRHVQTMYE | 111 | O60636 | |
| QLKTVLEMYGHFSGI | 461 | O43314 | |
| LEMYGHFSGINRKVQ | 466 | O43314 | |
| SQYQLMKHQSIRGFV | 796 | O60602 | |
| YLIGTNIFGILAHKM | 341 | Q05940 | |
| VLEMYGHFSGINRKV | 476 | Q6PFW1 | |
| GFRHGNVVAFIIEKM | 11 | Q9BXU2 | |
| LGRMGKHEQALFIYV | 696 | Q96JC1 | |
| QMLKGLRYIHAAGII | 136 | P53778 |